University Of Vermont Medical Center Dialysis Newport in Newport, Vermont - Dialysis Center

University Of Vermont Medical Center Dialysis Newport is a medicare approved dialysis facility center in Newport, Vermont and it has 9 dialysis stations. It is located in Orleans county at 189 Prouty Drive, Newport, VT, 05855. You can reach out to the office of University Of Vermont Medical Center Dialysis Newport at (802) 847-5411. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. University Of Vermont Medical Center Dialysis Newport has the following ownership type - Non-Profit. It was first certified by medicare in April, 2006. The medicare id for this facility is 473504 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameUniversity Of Vermont Medical Center Dialysis Newport
Location189 Prouty Drive, Newport, Vermont
No. of Dialysis Stations 9
Medicare ID473504
Managed ByIndependent
Ownership TypeNon-Profit
Late Shifts No

Contact Information


189 Prouty Drive, Newport, Vermont, 05855
(802) 847-5411

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with University Of Vermont Medical Center Dialysis Newport from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1538186168
Doing Business AsUniversity Of Vermont Medical Center Inc
Address189 Prouty Dr Newport, Vermont, 05855
Phone Number(802) 334-2711

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data16
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL6

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center22
    Adult patient months included in Kt/V greater than or equal to 1.2181
    Percentage of adult patients getting regular hemodialysis at the center98

    News Archive

    Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

    A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

    Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

    Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

    Endo announces acquisition of rights to Natesto (testosterone nasal gel)

    Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

    New food reports highlight growing global hunger

    Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

    Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

    Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

    Read more Medical News

    › Verified 1 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center1
    Adult patient months included in Kt/V greater than or equal to 1.712

    News Archive

    Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

    A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

    Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

    Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

    Endo announces acquisition of rights to Natesto (testosterone nasal gel)

    Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

    New food reports highlight growing global hunger

    Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

    Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

    Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

    Read more Medical News

    › Verified 1 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at University Of Vermont Medical Center Dialysis Newport with elevated calcium levels.

Patients with hypercalcemia23
Hypercalcemia patient months193
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor23
Patients with Serumphosphor less than 3.5 mg/dL3
Patients with Serumphosphor from 3.5 to 4.5 mg/dL26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL33
Patients with Serumphosphor from 5.6 to 7 mg/dL26
Patients with Serumphosphor greater than 7 mg/dL13

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 21
Patient months included in arterial venous fistula and catheter summaries 165
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment65
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer22

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary18
Hospitalization Rate in facility114.4 (As Expected)
Hospitalization Rate: Upper Confidence Limit344
Hospitalization Rate: Lower Confidence Limit41.5

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at University Of Vermont Medical Center Dialysis Newport get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.99 (As Expected)
SIR: Upper Confidence Limit4.79
SIR: Lower Confidence Limit.63

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether University Of Vermont Medical Center Dialysis Newport's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 17

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at University Of Vermont Medical Center Dialysis Newport lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary90
Mortality Rate in facility13 (As Expected)
Mortality Rate: Upper Confidence Limit22.3
Mortality Rate: Lower Confidence Limit6.9

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago


Dialysis Facility in Newport, VT

University Of Vermont Medical Center Dialysis Newport
Location: 189 Prouty Drive, Newport, Vermont, 05855
Phone: (802) 847-5411

News Archive

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VYVANSE® (lisdexamfetamine dimesylate capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents and adults.

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

New food reports highlight growing global hunger

Reforms are required to curb global hunger, which was already "growing" before the worldwide financial downturn, the U.N. Food and Agriculture Organization (FAO) and the World Food Programme (WFP) said in a report, released in Rome, ahead of World Food Day on Friday, the BBC reports (10/14).

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

Read more Medical News

› Verified 1 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.